Interestingly, we have recently reported increased levels of urinary Bcl-2 in ovarian cancer patients [28] suggesting that reduced epithelial Bcl-2 staining with tumor progression may reflect a transition from cellular expression of Bcl-2 to secreted Bcl-2 associated with disease progression. The gene discussed is BCL2; the disease is ovarian carcinoma.